TRAW

Traws Pharma, Inc.

Healthcare · Biotechnology

$175.69 sample

-2.02 (-1.14%) 1D

Market cap

$997.3B

Price as of

2026-10-03

Latest filing

8-K

Alerts

8

Price$175.69 +6.58% 3M daily closessample

177.71156.38

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider sell: Director
Sep 22INSInsider buy: Chief Financial Officer
Sep 14INSInsider sell: Chief Executive Officer
Sep 04INSInsider buy: General Counsel
Sep 01INSInsider buy: Chief Executive Officer
Aug 21INSInsider sell: EVP, Operations
Aug 12INSInsider buy: Chief Executive Officer
Aug 03INSInsider sell: EVP, Operations

Sign up to see the real TRAW record →

Company facts

SEC EDGAR registration

Name: Traws Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -41sample, -100 to +100
Reporting currency: USD

Who is positioning in TRAW

sample

Insiders: 22 insider transactions over 90 days, net selling, $504.1M
Congress: No member trades over 90 days
Institutions · 13F: 24 funds hold $7.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$65.9B +18.1% y/y

Q4 2024Q3 2026

Inventory$37.0B +8.4% y/y

Q4 2024Q3 2026

Accounts receivable$28.7B +12.0% y/y

Q4 2024Q3 2026

Total debt$74.2B +6.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $502.6B +10.9% 3M
Sample peer B: $618.2B -3.4% 3M
Sample peer C: $141.3B +16.4% 3M
Sample peer D: $125.9B +14.3% 3M
Sample peer E: $191.7B +3.3% 3M